Replies to post #1494 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

Why RVNC’s phase-3 trial in cervical dystonia is relatively well-suited to evaluating patient outcomes by telemedicine:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154609459

[DewDiligence]

RVNC Needham webcast today:

http://wsw.com/webcast/needham95/rvnc/